China Update:  State-owned giants seek to delist from the New York Stock Exchange China Update:  State-owned giants seek to delist from the New York Stock Exchange China Update:  State-owned giants seek to delist from the New York Stock Exchange

China Update: State-owned giants seek to delist from the New York Stock Exchange

Redmond Wong

Market Strategist, Greater China

Summary:  PetroChina, Sinopec, Sinopec Shanghai Petrochemical, Chalco and China Life Insurance notified the New York Stock Exchange on 12 Aug 2022 of their intended application for voluntary delisting of their American depository shares and terminating the relevant ADR programs. The question now is if this is an example set for mega-cap Chinese internet and platform companies to follow.


Five Chinese Central State-Owned Enterprises (“Central SOEs”) apply for delisting from the New York Stock Exchange

On August 12, 2022, after the close of the regular session of the Stock Exchange of Hong Kong, PetroChina (00857:xhkg/PTR:xnys), China Petroleum & Chemical Corporation, also known as Sinopec (00386:xhkg/SNP:xnys), Sinopec Shanghai Petrochemical (00338:xhkg/SHI:xnys), Aluminum Corporation of China, also known as Chalco (02600:xhkg/ACH:xnys), and China Life Insurance (02628:xhkg/LFC:xnys) announced that they had notified the New York Stock Exchange (“NYSE”) that they are will apply for delisting of their American depository shares (“ADSs”) from the NYSE. It is expected that the American Depository Receipt (“ADR”) programs will be terminated between September 1 and October 16, 2022, and the ADSs issued under these ADR programs can be surrendered for their underlying H shares, which will continue to trade in the Stock Exchange of Hong Kong (“SEHK”). 

PetroChina, Sinopec, Sinopec Shanghai Petrochemical and Chalco are Central SOEs that are owned (80.4%, 68.8%, 32.2%, and 50.4% respectively) and controlled by the State-owned Assets Supervision and Administration Commission of the State Council (“SASAC”).  These, together with 93 others that are also owned and controlled by the SASAC are known as Central SOEs or “Yang Qi” in Chinese.  China Life Insurance, not one of those under the SASAC, is not a Central SOE in the strict sense but it is usually considered a Central SOE due to the fact that it is 62.4% owned and controlled by the Ministry of Finance. 

All five companies are on the U.S. Securities and Exchange Commission’s (“SEC”) conclusive list of identified entities under the HFCAA 

In the U.S., the Sarbanes-Oxley Act enacted in 2002 requires publicly traded companies to give the U.S. Public Company Accounting Oversight Board (“PCAOB”) access to audit work papers. In 2009, the China Securities Regulatory Commission (“CSRC”) issued a rule that forbids overseas regulatory authorities from inspecting Chinese auditing firms without CSRC’s prior approval and audit work papers containing state secretes from being taken outside China.  The PCAOB’s attempt to inspect the China-based affiliates of the “Big”-4” accounting firms in 2010 was rejected by the CSRC.  The SEC subsequently prosecuted these China affiliates of the Big-4 and the cases were subsequently settled. 

In order to tighten the enforcement of the audit work papers requirement provided in the Sarbanes-Oxley Act, the U.S. enacted the Holding Foreign Companies Accountable Act (“HFCAA”) in 2020 which provides that companies failing to make available audit work papers for inspection by the PCAOB cannot be traded in a U.S. exchange.  Since March 2022, the SEC has put 162 Chinese companies listed in a U.S. bourse first on a provisional list and then 155 of them subsequently on a conclusive list of issuers identified under the HFCAA. 

After rounds of negotiations, the U.S. and China have so far not been able to come to some resolutions.  While the Chinese authorities have sounded optimistic, especially earlier in April and May, about eventually reaching an agreement with the U.S., SEC Chairman Gary Gensler has expressed doubts about any eventual agreement.

PetroChina, Sinopec, Sinopec Shanghai Petrochemical, Chalco, and China Life Insurance are among those on the conclusive list and facing the plausibility of being delisted by the U.S. regulators from the NYSE.  The deadline for delisting is in 2024 but the U.S. Congress is considering passing a bill to bring the deadline forward to 2023. 

Actions were seemingly in concert 

Each of the five companies notified the NYSE on the same day, August 12, and provided similar reasons for their decisions in their filing with the SEHK, namely relatively small capitalization of H shares being represented by ADSs, small ADS trading volume compared to the turnover of H shares and administrative burden for performing reporting and disclosure. The China Securities Regulatory Commission (“CSRC”) said on Friday that the delisting decision had been made out of these companies’ own business decisions. Nonetheless, given the identical timing, similar reasons provided and status of Central SOEs, one has to wonder if they were acting in concert with coordination from the Chinese authorities.  The other two Central SOEs controlled by the SACAC and on the SEC conclusive list, China Eastern Airlines (00670:xhkg/CEA:xnys) and China Southern Airlines (01055:xhkg/ZNH:xnys) will probably apply for ADS delisting soon as well. 

Chinese internet and platform companies are the focus in the coming weeks 

While these Central SOEs are thinly traded on the NYSE, the shares of Chinese internet and platform private enterprises, including Alibaba (09988:xhkg/BABA:xnys), Baidu (09888:xhkg/BIDU:xnas), Bilibili (09626:xhkg/BILI:xnas), JD.COM (09618:xhkg/JD:xnas), Pinduoduo (PDD:xnas), Sohu (SOHU:xnas), iQiyi (IQ:xnas), KE Holdings (BEKE:xnys), Weibo (09898:xhkg/WB:xnas), Tencent Music Entertainment (TME:xnys) are widely held and actively traded on the NYSE or Nasdaq.  For examples, Bilibili and Weibo have larger average daily turnover in Nasdaq than in the SEHK and Pinduoduo, iQiyi, KE Holdings, Sohu and are listed only on Nasdaq and Tencent Music on the NYSE.  

Alibaba is on the provisional list and the other names above are on the conclusive list of issuers identified under the HFCAA. All of them will be subject to mandatory delisting from the NYSE or Nasdaq if the Chinese and U.S. regulators cannot reach an agreement to resolve the audit work paper inspection issue in the coming months.  

Given these internet and platform companies hold a huge amount of potentially sensitive data of hundreds of millions of Chinese individuals as well as numerous private as well as public enterprises and institutions, the plausibility of the Chinese government being willing to make a concession to the SEC and PCAOB regarding the latter’s unfiltered access to audit work papers of these companies is getting increasingly slim in the midst of pervasive Sino-American strategic competition.  

Through the voluntary delisting of Central SOEs, the Chinese authorities may have set an example for the internet and platform companies to follow.  If that happens to be the case, the share prices of these internet and platform giants will be facing more headwinds as we set out in a previous article.  Some U.S. institutional money which is restricted by their investment mandates and retail investors who tend to have a home bias will unload their holdings instead of exchanging their ADSs for H shares.  In the case of those companies that do not yet have a listing in the SEHK, the uncertainty and disruption will be even more significant.  The southbound stock connect flows of money from mainland investors may mitigate somewhat the impact but some turbulence initially can probably be expected.

免責條款

盛寶銀行集團各實體均提供只限執行的服務和分析存取權限,允許客戶查詢和/或使用在網站或透過網站提供的內容。此內容不是為了且也不會改變或拓展只限執行的服務。這種存取權限和使用情況一律受到以下約束:(i)使用條款;(ii)完整免責條款;(iii)風險警告;(iv)參與規則,及(v)適用於「盛寶新聞與研究」和/或其內容的通知,以及(在相關情況下)適用的條款,以監管盛寶銀行集團成員網站上的超連結的使用情況(透過這些連結可存取「盛寶新聞與研究」)。因此,該等內容僅作為資訊提供。當中需特別注意,一切顧問建議均不得視為由任何盛寶銀行集團實體提供或推薦,亦不應解釋為向您提供任何訂購、買入或售出金融工具的誘因或動機。您的一切交易或投資行動,必須為個人自行作出、完全知情的決定。因此,如果您因根據「盛寶新聞與研究」提供的資訊作出任何投資決定或由於使用「盛寶新聞與研究」而蒙受損失,盛寶銀行集團實體將不會承擔任何責任。所發出的訂單和已生效的交易應視為打算在客戶所在的轄區和/或客戶開設並維護其交易賬戶的轄區內的盛寶銀行集團實體下為客戶的賬戶發出或執行。「盛寶新聞與研究」不包含(並且不應解釋為包含)財務、投資、稅收或交易建議,或盛寶銀行集團提供、推薦或認可的任何形式的建議,並且不應解釋為我們的交易價格記錄,或在任何金融工具中作出認購、出售或購買的提議、激勵或要求。對於任何被解釋為投資研究的內容而言,您必須注意並接受,該內容並非旨在,也未根據旨在促進投資研究獨立性的法律要求而準備,因此應被視為根據相關法律提供的營銷通訊。

請參閱我們的免責條款:
非獨立投資研究通知 (https://www.home.saxo/legal/niird/notification)
完整免責條款 (https://www.home.saxo/legal/disclaimer/saxo-disclaimer)
完整免責條款 (https://www.home.saxo/legal/saxoselect-disclaimer/disclaimer)

盛寶金融 (香港) 有限公司
中環皇后大道中12號
上海商業銀行大廈19樓

聯絡盛寶

請選擇地區

中國香港
中國香港

盛寶金融(香港)有限公司持有由香港證券及期貨事務監察委員會發出的第1類受規管活動 (證券交易)﹔第2類受規管活動(期貨交易) ﹔第3類受規管活動(槓桿式外匯交易) ﹔第4類受規管活動(就證券提供意見) 及第9類受規管活動(提供資產管理)的牌照(中央號碼:AVD061)。註冊地址:中環皇后大道中12號上海商業銀行大廈19樓

點擊本站的連結,代表您瞭解和同意離開盛寶金融網站,前往由盛寶銀行集團管理的網站,並接受其條款的約束。

Apple,iPad和iPhone是Apple Inc.在美國和其他國家註冊的商標。 AppStore是Apple Inc.的服務標誌。

本網站所提供的信息以及盛寶金融提供的任何產品和服務不適用於美國和日本居住的投資者,亦非意圖分發給會違反當地國家或轄區內之法律或法規的任何人。請點擊查看完整免責聲明。